$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Enterprise License

Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021
[Published by MarketsandMarkets]

Published by MarketsandMarkets: 14 Jun 2016 | 19951 | In Stock
Related Topics: Nursing

Introduction

“Infection Surveillance Solutions Market, By Product [Software (On Premise, Web Based), Services (Training & Consulting, Implementation)], By End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021”

The global infection surveillance solutions market is expected to grow at a CAGR of 14.1% during the forecast period of 2016-2021 and is estimated at USD 508.8 million in 2021. The market is mainly driven by factors such as increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditure, and increasing number of surgeries. However, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare tools, and dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of the infection surveillance solutions market to a certain extent.

In this report, the global infection surveillance solutions market is segmented by product, end user, and region.

On the basis of products, the market is classified into software and services. The software segment is further segmented into on-premise and web-based software. The services included in this report are subdivided into product support & maintenance, training & consulting, and implementation services. By end user, the infection surveillance solutions market is segmented into hospitals and long-term care facilities. Hospitals are further sub-divided on the basis of bed size into large, medium-sized, and small hospitals. Long-term care facilities included in this report are nursing homes, skilled nursing facilities, and assisted living facilities.

Geographically, North America accounted for the largest share of the global infection surveillance solutions market in 2015, followed by Europe, Asia-Pacific, and the RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The Asia-Pacific region is expected to record the highest market growth during the forecast period due to the rising incidences of HAIs, increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, and rapid improvements in the health insurance sector in this region.

In 2015, Becton, Dickinson and Company (U.S.), Premier Inc. (U.S.), Wolters Kluwer N.V. (Netherlands,), Baxter International Inc. (U.S.), and GOJO Industries, Inc. (U.S.) among others, were the leading players in the infection surveillance solutions market.

Reasons to Buy the Report

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the infection surveillance solutions market. The report analyzes the infection surveillance solutions market by product and end user across all regions

• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and new product launches in the infection surveillance solutions market

• Market Development: Comprehensive information of the lucrative emerging markets by product, end user, and region

• Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the global infection surveillance solutions market

• Competitive Assessment: In-depth assessment of growth strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global infection surveillance solutions market

Table of Contents
for Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021 [Published by MarketsandMarkets]

  • TABLE OF CONTENTS

    1 INTRODUCTION 17

    1.1 OBJECTIVES OF THE STUDY 17

    1.2 MARKET DEFINITION 17

    1.3 MARKET SCOPE 17

    1.3.1 MARKETS COVERED 18

    1.3.2 YEARS CONSIDERED FOR THE STUDY 18

    1.4 CURRENCY 19

    1.5 LIMITATIONS 19

    1.6 STAKEHOLDERS 19

    2 RESEARCH METHODOLOGY 20

    2.1 RESEARCH APPROACH 20

    2.2 MARKET SIZE ESTIMATION 22

    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24

    2.4 SECONDARY SOURCES 25

    2.4.1 KEY DATA FROM SECONDARY SOURCES 25

    2.5 PRIMARY SOURCES 26

    2.5.1 KEY DATA FROM PRIMARY SOURCES 26

    2.5.2 KEY INDUSTRY INSIGHTS FROM PRIMARY SOURCES 27

    2.6 ASSUMPTIONS FOR THE STUDY 27

    3 EXECUTIVE SUMMARY 28

    4 PREMIUM INSIGHTS 34

    4.1 INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW 34

    4.2 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT 35

    4.3 GEOGRAPHIC SNAPSHOT: INFECTION SURVEILLANCE SOLUTIONS MARKET 36

    4.4 NORTH AMERICA TO DOMINATE THE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING THE FORECAST PERIOD 37

    4.5 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 38

    5 MARKET OVERVIEW 39

    5.1 INTRODUCTION 40

    5.2 MARKET SEGMENTATION 40

    5.2.1 BY PRODUCTS & SERVICES 40

    5.2.2 BY END USER 40

    5.3 MARKET DYNAMICS 41

    5.3.1 MARKET DRIVERS 42

    5.3.1.1 Increasing incidence of HAIs 42

    5.3.1.2 Government policies for preventing HAIs 43

    5.3.1.3 Increasing healthcare expenditure 43

    5.3.1.4 Increasing number of surgeries 44

    5.3.2 MARKET RESTRAINTS 46

    5.3.2.1 High cost of software 46

    5.3.2.2 Reluctance among medical professionals to adopt advanced healthcare tools 46

    5.3.2.3 Dearth of skilled IT professionals in the healthcare industry 46

    5.3.3 MARKET OPPORTUNITIES 47

    5.3.3.1 Cloud-based software offers significant growth opportunities 47

    5.3.3.2 High growth in developing counties across APAC and Latin America 47

    5.3.4 MARKET CHALLENGES 48

    5.3.4.1 Under developed IT infrastructure in developing countries 48

    5.4 INDUSTRY TRENDS 49

    5.4.1 SHIFT TOWARDS AUTOMATION IN HEALTHCARE FACILITIES 49

    5.4.2 GROWING DEMAND FOR WEB-BASED SOLUTIONS AND MOBILE PLATFORMS 49

    5.5 KEY BUYING CRITERIA 50

    6 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT 52

    6.1 INTRODUCTION 53

    6.2 SOFTWARE 54

    6.2.1 ON-PREMISE SOFTWARE 56

    6.2.2 WEB-BASED SOFTWARE 57

    6.3 SERVICES 58

    6.3.1 PRODUCT SUPPORT & MAINTENANCE SERVICES 60

    6.3.2 TRAINING & CONSULTING SERVICES 61

    6.3.3 IMPLEMENTATION SERVICES 62

    7 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER 63

    7.1 INTRODUCTION 64

    7.2 HOSPITALS 65

    7.2.1 LARGE HOSPITALS 67

    7.2.2 MEDIUM-SIZED HOSPITALS 68

    7.2.3 SMALL HOSPITALS 69

    7.3 LONG-TERM CARE FACILITIES 70

    7.3.1 NURSING HOMES 72

    7.3.2 SKILLED NURSING FACILITIES 73

    7.3.3 ASSISTED LIVING FACILITIES 74

    7.4 OTHER END USERS 75

    8 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION 76

    8.1 INTRODUCTION 77

    8.2 NORTH AMERICA 79

    8.2.1 U.S. 85

    8.2.2 CANADA 89

    8.3 EUROPE 94

    8.3.1 GERMANY 98

    8.3.2 FRANCE 102

    8.3.3 U.K. 107

    8.3.4 ITALY 111

    8.3.5 SPAIN 115

    8.3.6 REST OF EUROPE 119

    8.4 ASIA-PACIFIC 123

    8.4.1 JAPAN 129

    8.4.2 CHINA 133

    8.4.3 INDIA 137

    8.4.4 REST OF ASIA-PACIFIC 141

    8.5 REST OF THE WORLD 145

    8.5.1 LATIN AMERICA 148

    8.5.2 MIDDLE EAST AND AFRICA 152

    9 COMPETITIVE LANDSCAPE 156

    9.1 OVERVIEW 156

    9.2 LEADING PLAYERS IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET 157

    9.3 COMPETITIVE SITUATION AND TRENDS 159

    9.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 160

    9.3.2 PRODUCT ENHANCEMENTS 161

    9.3.3 ACQUISITIONS 162

    9.3.4 NEW PRODUCT LAUNCHES 163

    9.3.5 EXPANSIONS 164

    10 COMPANY PROFILES 165

    (Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*

    10.1 INTRODUCTION 165

    10.2 BECTON, DIKINSON AND COMPANY 166

    10.3 PREMIER INC. 168

    10.4 WOLTERS KLUWER N.V. 170

    10.5 BAXTER INTERNATIONAL INC. 173

    10.6 GOJO INDUSTRIES, INC. 176

    10.7 RL SOLUTIONS 178

    10.8 TRUVEN HEALTH ANALYTICS (AN IBM COMPANY) 180

    10.9 DEB GROUP LTD. 182

    10.10 HYGREEN, INC. 183

    10.11 ATLAS MEDICAL SOFTWARE 184

    *Details on company financial might not be captured in case of unlisted companies

    11 APPENDIX 185

    11.1 INSIGHTS OF INDUSTRY EXPERTS 185

    11.2 DISCUSSION GUIDE 186

    11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 189

    11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 191

    11.5 AVAILABLE CUSTOMIZATIONS 192

    11.6 RELATED REPORTS 193

List Of Tables
in Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021 [Published by MarketsandMarkets]

LIST OF TABLES


TABLE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT, 2016 VS. 2021 28

TABLE 2 PRINCIPAL OPERATIVE PROCEDURES WITH HIGH RISK OF SSIS 45

TABLE 3 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY PRODUCT, 2014-2021 (USD MILLION) 53

TABLE 4 GLOBAL INFECTION SURVEILLANCE SOFTWARE MARKET SIZE,

BY TYPE, 2014-2021 (USD MILLION) 55

TABLE 5 GLOBAL INFECTION SURVEILLANCE SOFTWARE MARKET SIZE,

BY COUNTRY/REGION, 2014-2021 (USD MILLION) 55

TABLE 6 GLOBAL ON-PREMISE INFECTION SURVEILLANCE SOFTWARE MARKET SIZE,

BY COUNTRY/REGION, 2014-2021 (USD MILLION) 56

TABLE 7 GLOBAL WEB-BASED INFECTION SURVEILLANCE SOFTWARE MARKET SIZE,

BY COUNTRY/REGION, 2014-2021 (USD MILLION) 57

TABLE 8 GLOBAL INFECTION SURVEILLANCE SERVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 59

TABLE 9 GLOBAL INFECTION SURVEILLANCE SERVICES MARKET SIZE,

BY COUNTRY/REGION, 2014-2021 (USD MILLION) 59

TABLE 10 GLOBAL PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET SIZE,

BY COUNTRY/REGION, 2014-2021 (USD MILLION) 60

TABLE 11 GLOBAL TRAINING AND CONSULTING SERVICES MARKET SIZE,

BY COUNTRY/REGION, 2014-2021 (USD MILLION) 61

TABLE 12 GLOBAL IMPLEMENTATION SERVICES MARKET SIZE, BY COUNTRY/REGION,

2014-2021 (USD MILLION) 62

TABLE 13 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 64

TABLE 14 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 66

TABLE 15 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY COUNTRY/REGION, 2014–2021 (USD MILLION) 66

TABLE 16 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LARGE HOSPITALS, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 67

TABLE 17 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 68

TABLE 18 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR SMALL HOSPITALS, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 69

TABLE 19 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021(USD MILLION) 71

TABLE 20 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY COUNTRY/REGION, 2013–2020 (USD MILLION) 71

TABLE 21 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR NURSING HOMES, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 72

TABLE 22 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR SKILLED NURSING FACILITIES, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 73

TABLE 23 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR ASSISTED LIVING FACILITIES, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 74

TABLE 24 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR OTHER END USERS, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 75

TABLE 25 GLOBAL: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 78

TABLE 26 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY COUNTRY, 2014–2021 (USD MILLION 81

TABLE 27 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY PRODUCT, 2014–2021 (USD MILLION) 82

TABLE 28 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 82

TABLE 29 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY SERVICE TYPE, 2014–2021 (USD MILLION) 83

TABLE 30 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY END USER, 2014–2021 (USD MILLION) 83

TABLE 31 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014–2021 (USD MILLION) 84

TABLE 32 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 84

TABLE 33 U.S.: MARKET INDICATORS 86

TABLE 34 U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 87

TABLE 35 U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 87

TABLE 36 U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 88

TABLE 37 U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 88

TABLE 38 U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 88

TABLE 39 U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 89

TABLE 40 CANADA: MARKET INDICATORS 90

TABLE 41 CANADA.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 91

TABLE 42 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 91

TABLE 43 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 92

TABLE 44 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 92

TABLE 45 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 93

TABLE 46 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 93

TABLE 47 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION 95

TABLE 48 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 95

TABLE 49 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 96

TABLE 50 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 96

TABLE 51 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 96

TABLE 52 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 97

TABLE 53 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 97

TABLE 54 GERMANY: MARKET INDICATORS 99

TABLE 55 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 100

TABLE 56 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 100

TABLE 57 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 100

TABLE 58 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 101

TABLE 59 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014–2021 (USD MILLION) 101

TABLE 60 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 102

TABLE 61 FRANCE: MARKET INDICATORS 103

TABLE 62 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 104

TABLE 63 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 104

TABLE 64 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 105

TABLE 65 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 105

TABLE 66 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 106

TABLE 67 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 106

TABLE 68 U.K.: MARKET INDICATORS 108

TABLE 69 U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 109

TABLE 70 U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 109

TABLE 71 U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 109

TABLE 72 U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 110

TABLE 73 U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 110

TABLE 74 U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 111

TABLE 75 ITALY: MARKET INDICATORS 112

TABLE 76 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 113

TABLE 77 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 113

TABLE 78 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 113

TABLE 79 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 114

TABLE 80 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 114

TABLE 81 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 115

TABLE 82 SPAIN: MARKET INDICATORS 116

TABLE 83 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 117

TABLE 84 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 117

TABLE 85 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 117

TABLE 86 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 118

TABLE 87 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 118

TABLE 88 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 119

TABLE 89 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 120

TABLE 90 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 120

TABLE 91 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 121

TABLE 92 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 121

TABLE 93 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 122

TABLE 94 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 122

TABLE 95 APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 126

TABLE 96 APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 126

TABLE 97 APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 126

TABLE 98 APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 127

TABLE 99 APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 127

TABLE 100 APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 128

TABLE 101 APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 128

TABLE 102 JAPAN: MARKET INDICATORS 129

TABLE 103 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 130

TABLE 104 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 130

TABLE 105 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 131

TABLE 106 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 131

TABLE 107 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 132

TABLE 108 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 132

TABLE 109 CHINA: MARKET INDICATORS 133

TABLE 110 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 134

TABLE 111 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 134

TABLE 112 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 135

TABLE 113 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 135

TABLE 114 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 136

TABLE 115 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 136

TABLE 116 INDIA: MARKET INDICATORS 137

TABLE 117 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 139

TABLE 118 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 139

TABLE 119 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 139

TABLE 120 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 140

TABLE 121 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 140

TABLE 122 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 141

TABLE 123 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 142

TABLE 124 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 142

TABLE 125 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 143

TABLE 126 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 143

TABLE 127 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 144

TABLE 128 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 144

TABLE 129 ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 145

TABLE 130 ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 146

TABLE 131 ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 146

TABLE 132 ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 146

TABLE 133 ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 147

TABLE 134 ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2014–2021 (USD MILLION) 147

TABLE 135 ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 148

TABLE 136 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY PRODUCT, 2014–2021 (USD MILLION) 149

TABLE 137 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 149

TABLE 138 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY SERVICES TYPE, 2014–2021 (USD MILLION) 150

TABLE 139 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE,

BY END USER, 2014–2021 (USD MILLION) 150

TABLE 140 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014–2021 (USD MILLION) 151

TABLE 141 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 151

TABLE 142 MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 153

TABLE 143 MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014–2021 (USD MILLION) 153

TABLE 144 MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014–2021 (USD MILLION) 153

TABLE 145 MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 154

TABLE 146 MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014–2021 (USD MILLION) 154

TABLE 147 MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014–2021 (USD MILLION) 155

TABLE 148 KEY PLAYERS IN THE GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET 157

TABLE 149 GROWTH STRATEGY MATRIX (2012–2016) 159

TABLE 150 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2013–2015 160

TABLE 151 PRODUCT ENHANCEMENTS, 2012–2015 161

TABLE 152 ACQUISITIONS, 2014–2016 162

TABLE 153 NEW PRODUCT LAUNCHES, 2013–2015 163

TABLE 154 EXPANSIONS, 2013–2015 164

List Of Figures, Charts and Diagrams
in Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021 [Published by MarketsandMarkets]

LIST OF FIGURES


FIGURE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET 18

FIGURE 2 RESEARCH DESIGN 21

FIGURE 3 BOTTOM-UP APPROACH 23

FIGURE 4 TOP-DOWN APPROACH 23

FIGURE 5 DATA TRIANGULATION METHODOLOGY 24

FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 26

FIGURE 7 INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT,

2016 VS. 2021 (USD MILLION) 29

FIGURE 8 INFECTION SURVEILLANCE SOFTWARE MARKET SIZE, BY TYPE,

2016 VS. 2021 (USD MILLION) 29

FIGURE 9 INFECTION SURVEILLANCE SERVICES MARKET SIZE, BY TYPE,

2016 VS. 2021 (USD MILLION) 30

FIGURE 10 INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER,

2016 VS. 2021 (USD MILLION) 31

FIGURE 11 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS,

BY TYPE, 2016 VS. 2021 (USD MILLION) 31

FIGURE 12 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2016 VS. 2021 (USD MILLION) 32

FIGURE 13 GEOGRAPHIC ANALYSIS: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET 33

FIGURE 14 INCREASING INCIDENCE OF HEALTHCARE-ASSOCIATED INFECTIONS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 34

FIGURE 15 U.S. HELD THE LARGEST SHARE OF THE NORTH AMERICAN INFECTION SURVEILLANCE SOLUTIONS MARKET IN 2015 35

FIGURE 16 CHINA & JAPAN PROVIDE HIGH GROWTH POTENTIAL FOR INFECTION SURVEILLANCE SOLUTIONS MARKET 36

FIGURE 17 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC MIX 37

FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 38

FIGURE 19 INFECTION SURVEILLANCE SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41

FIGURE 20 COMMON HEALTHCARE-ASSOCIATED INFECTIONS IN THE U.S. ACUTE CARE HOSPITALS 43

FIGURE 21 GLOBAL HEALTHCARE EXPENDITURE, 2003-2013 44

FIGURE 22 HEALTHCARE EXPENDITURE GROWTH RATE ACROSS KEY GEOGRAPHIES 48

FIGURE 23 KEY INDUSTRY TRENDS 49

FIGURE 24 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT,

2016 VS. 2021 (USD MILLION) 53

FIGURE 25 GLOBAL INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,

2016 VS. 2021 (USD MILLION) 54

FIGURE 26 GLOBAL INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,

2016 VS. 2021 (USD MILLION) 58

FIGURE 27 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER,

2016 VS. 2021 (USD MILLION) 64

FIGURE 28 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,

BY TYPE, 2016 VS. 2021 (USD MILLION) 65

FIGURE 29 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2016 VS. 2021 (USD MILLION) 70

FIGURE 30 GEOGRAPHIC SNAPSHOT (2016-2021): ASIA-PACIFIC, AN EMERGING GROWTH HOTSPOT 77

FIGURE 31 NORTH AMERICAN INFECTION SURVEILLANCE SOLUTIONS MARKET

SNAPSHOT, 2016 80

FIGURE 32 NORTH AMERICA: HEALTHCARE EXPENDITURE, 2003-2013 81

FIGURE 33 U.S.: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012 85

FIGURE 34 U.S.: HEALTHCARE EXPENDITURE, 2003-2013 86

FIGURE 35 CANADA: HEALTHCARE EXPENDITURE, 2003-2013 90

FIGURE 36 EUROPE: HEALTHCARE EXPENDITURE, 2003-2013 94

FIGURE 37 GERMANY: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED

INFECTIONS, 2012 98

FIGURE 38 GERMANY: HEALTHCARE EXPENDITURE, 2003-2013 99

FIGURE 39 FRANCE: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED

INFECTIONS, 2012 102

FIGURE 40 FRANCE: HEALTHCARE EXPENDITURE, 2003-2013 103

FIGURE 41 U.K.: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012 107

FIGURE 42 U.K.: HEALTHCARE EXPENDITURE, 2003-2013 108

FIGURE 43 ITALY: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012 111

FIGURE 44 ITALY: HEALTHCARE EXPENDITURE, 2003-2013 112

FIGURE 45 SPAIN: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012 115

FIGURE 46 SPAIN: HEALTHCARE EXPENDITURE, 2003-2013 116

FIGURE 47 ROE: HEALTHCARE EXPENDITURE, 2003-2013 119

FIGURE 48 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT, 2016 124

FIGURE 49 APAC: HEALTHCARE EXPENDITURE, 2003-2013 125

FIGURE 50 JAPAN: HEALTHCARE EXPENDITURE, 2003-2013 129

FIGURE 51 CHINA: HEALTHCARE EXPENDITURE, 2003-2013 133

FIGURE 52 INDIA: HEALTHCARE EXPENDITURE, 2003-2013 138

FIGURE 53 ROAPAC: HEALTHCARE EXPENDITURE, 2003-2013 141

FIGURE 54 LATIN AMERICA: HEALTHCARE EXPENDITURE, 2003-2013 148

FIGURE 55 MIDDLE EAST AND AFRICA: HEALTHCARE EXPENDITURE, 2003-2013 152

FIGURE 56 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS (2012–2016) 156

FIGURE 57 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS (2012–2016) 160

FIGURE 58 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR PLAYERS 165

FIGURE 59 COMPANY SNAPSHOT: BECTON, DIKINSON AND COMPANY 166

FIGURE 60 COMPANY SNAPSHOT: PREMIER INC. 168

FIGURE 61 COMPANY SNAPSHOT: WOLTERS KLUWER N.V. 170

FIGURE 62 COMPANY SNAPSHOT: BAXTER INTERNATIONAL INC. 173

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

19951 | HIT 4380

Number of Pages

194

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical tr...
25 Oct 2018 by Global Data USD $2,500 More Info
Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022
Healthcare associated infections which mainly includes hospital or community acquired infections are...
21 Sep 2016 by IQ4I USD $4,950 More Info
Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022
Healthcare associated infections which mainly includes hospital or community acquired infections are...
21 Sep 2016 by IQ4I USD $4,950 More Info
Hazmat Suits Market by Application (Chemical Waste, Infection Control & Bio-Hazard, Hazardous Material), End-Use (Oil & Gas, Mining & Metallurgy, Construction, Manufacturing, Transportation, Utilities, Healthcare), Safety Standards - Global Forecast to 2021
“The hazmat suits market is projected to reach USD 7.97 billion by 2021”Hazmat suits are used at maj...
13 Sep 2016 by MarketsandMarkets USD $5,650 More Info
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tr...
31 May 2016 by Global Data USD $2,500 More Info
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tr...
31 May 2016 by Global Data USD $2,500 More Info
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical...
20 Jan 2016 by Global Data USD $2,500 More Info
EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024
EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024SummaryRSV is a...
23 Dec 2015 by Global Data USD $3,995 More Info
Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015
Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinica...
25 Nov 2015 by Global Data USD $2,500 More Info
Rhinovirus Infection Global Clinical Trials Review, H2, 2015
Rhinovirus Infection Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial repor...
25 Nov 2015 by Global Data USD $2,500 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021 [Published by MarketsandMarkets] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...